The AHA, 340B Health, the Maryland Hospital Association and the Mid-Atlantic Association of Community Health Centers June 26 filed an amicus brief in a federal district court in Maryland, defending the state's law protecting 340B pricing for contract pharmacy arrangements. Similar to a brief filed last week in Mississippi, Novartis Pharmaceuticals is also seeking a preliminary injunction against enforcement of the law in Maryland. 

Related News Articles

Headline
The AHA, 340B Health, Maryland Hospital Association and Mid-Atlantic Association of Community Health Centers July 9 filed an amicus brief in a federal district…
Headline
A federal court in Texas last week found that the Federal Trade Commission likely lacked statutory authority to issue its Non-Compete Clause Final Rule. The…
Headline
In a letter submitted July 2 to the Centers for Medicare & Medicaid Services on guidance for the Medicare Drug Price Negotiation Program, the AHA expressed…
Headline
A Mississippi judge July 1 denied Novartis Pharmaceuticals’ and PhRMA’s request for a preliminary injunction against enforcement of state law protecting 340B…
Headline
The Supreme Court June 28 overturned a 1984 ruling in Chevron U.S.A., Inc. v. Natural Resources Defense Council, Inc., which required courts to defer to…
Headline
The Supreme Court June 27 dismissed a case about whether an Idaho law can coexist with the federal Emergency Medical Treatment and Active Labor Act (EMTALA),…